Home › Recently closed › 2026-11691
Drug Repurposing for Unmet Medical Needs; Request for Information; Extension of Comment Period
Read on FederalRegister.gov · Official PDF · Docket on Regulations.gov · Add to calendar (.ics)
Summary (from the Federal Register abstract)
The Food and Drug Administration (FDA, the Agency, or we) is extending the comment period for the notice entitled "Drug Repurposing for Unmet Medical Needs; Request for Information" that appeared in the Federal Register of May 12, 2026 (91 FR 25897). In the notice, FDA requested comments to solicit input on FDA's efforts with respect to drug repurposing to address unmet medical needs. The Agency is taking this action to allow interested persons additional time to submit comments.
- Document type
- Notice
- Federal Register document number
- 2026-11691
- Published
- Jun 11, 2026
- Action
- Notice; request for information; establishment of a public docket.
- Docket
- FDA-2026-N-4492
- Comments posted on Regulations.gov (at last check)
- 0
- DATES section (from the document)
- FDA is extending the comment period for the notice published May 12, 2026 (91 FR 25897). Submit either electronic or written comments, data, or information by July 13, 2026.
- Topics (auto-tagged)
- Other FDA topics
Source: Federal Register API, document 2026-11691. Federal Register text is a U.S. government work. Confirm dates in the official document; later documents may extend, reopen or correct them.